Hoxton Financial’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Hoxton Financial’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4K	Buy	1,300 +400	+44%	+$1.48K	﹤0.01%	303
2015 Q4	$4K	Hold	900	–	–	﹤0.01%	272
2015 Q3	$5K	Buy	900 +300	+50%	+$2.21K	﹤0.01%	272
2015 Q2	$5K	Hold	600	–	–	﹤0.01%	279
2015 Q1	$6K	Hold	600	–	–	﹤0.01%	260
2014 Q4	$7K	Buy	600 +200	+50%	+$3.04K	﹤0.01%	259
2014 Q3	$7K	Hold	400	–	–	﹤0.01%	230
2014 Q2	$5K	Hold	400	–	–	﹤0.01%	252
2014 Q1	$3K	Hold	400	–	–	﹤0.01%	287
2013 Q4	$2K	Hold	400	–	–	﹤0.01%	662
2013 Q3	$2K	Hold	400	–	–	﹤0.01%	425
2013 Q2	$2K	Buy	+400	New	+$1.88K	﹤0.01%	604

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Hoxton Financial's BDSI Position: Q1 2016 in Review

Hoxton Financial increased its BioDelivery Sciences International, Inc. (BDSI) stake by 44% in Q1 2016, buying an estimated $1.48K and bringing the position to 1,300 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

Hoxton Financial first reported a position in BDSI in Q2 2013 and has held it in 12 quarters since. The position peaked at $7K in Q4 2014. 105 funds tracked by Wall St. Rank hold BDSI as of Q1 2016.

Hoxton Financial held 1,300 shares of BioDelivery Sciences International, Inc. worth $4K as of Q1 2016.
Hoxton Financial bought 400 BioDelivery Sciences International, Inc. shares in Q1 2016, an estimated $1.48K.
BioDelivery Sciences International, Inc. made up ﹤0.01% of Hoxton Financial's portfolio in Q1 2016, its #303 holding.
Hoxton Financial first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and has held it in 12 quarters since.
Hoxton Financial's BioDelivery Sciences International, Inc. position peaked at $7K in Q4 2014.
105 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.